Atlas Trials

To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines.

Clinical trial NCT04944953 · COMPLETED

Trial details

NCT number
NCT04944953
Sponsor
Hugel
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Glabellar Lines
Start date
2021-06-11
Primary completion
2021-09-02
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.